Wells Trecaso Financial Group, LLC Abbott Laboratories Transaction History

Wells Trecaso Financial Group, LLC

$300 Million
Q1 2025

A detailed history of Wells Trecaso Financial Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Wells Trecaso Financial Group, LLC holds 9,142 shares of ABT stock, worth $1.2 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

9,142

Previous 9,542 4.19%

Holding current value

$1.2 Million

Previous $1.08 Million 12.33%

% of portfolio

0.4%

Previous 0.35%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 18, 2025	SELL	$111.1 - $140.22 $44,440 - $56,088	-400 Reduced 4.19%	9,142 $1.21 Million
Q4 2024 Jan 17, 2025	SELL	$111.93 - $119.39 $50,368 - $53,725	-450 Reduced 4.5%	9,542 $1.08 Million
Q3 2024 Oct 24, 2024	SELL	$100.07 - $118.13 $50,035 - $59,065	-500 Reduced 4.77%	9,992 $1.14 Million
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $41,198 - $45,987	-409 Reduced 3.75%	10,492 $1.09 Million
Q1 2024 Apr 24, 2024	SELL	$109.52 - $120.96 $138,652 - $153,135	-1,266 Reduced 10.41%	10,901 $1.24 Million
Q4 2023 Jan 19, 2024	SELL	$90.19 - $110.4 $13,438 - $16,449	-149 Reduced 1.21%	12,167 $1.34 Million
Q3 2023 Oct 23, 2023	SELL	$95.53 - $114.62 $32,002 - $38,397	-335 Reduced 2.65%	12,316 $1.19 Million
Q2 2023 Jul 20, 2023	SELL	$100.78 - $112.29 $1,814 - $2,021	-18 Reduced 0.14%	12,651 $1.38 Million
Q1 2023 Apr 20, 2023	SELL	$96.86 - $114.01 $1,356 - $1,596	-14 Reduced 0.11%	12,669 $1.28 Million
Q4 2022 Jan 27, 2023	BUY	$95.06 - $111.52 $3,041 - $3,568	32 Added 0.25%	12,683 $0
Q3 2022 Oct 24, 2022	SELL	$96.76 - $112.03 $6,482 - $7,506	-67 Reduced 0.53%	12,651 $1.22 Million
Q2 2022 Jul 27, 2022	SELL	$102.07 - $123.37 $24,905 - $30,102	-244 Reduced 1.88%	12,718 $1.38 Million
Q1 2022 Apr 14, 2022	SELL	$114.02 - $139.04 $51,765 - $63,124	-454 Reduced 3.38%	12,962 $1.53 Million
Q4 2021 Jan 31, 2022	SELL	$115.53 - $141.46 $34,659 - $42,438	-300 Reduced 2.19%	13,416 $1.89 Million
Q3 2021 Nov 09, 2021	SELL	$116.66 - $129.06 $61,246 - $67,756	-525 Reduced 3.69%	13,716 $1.62 Million
Q2 2021 Jul 29, 2021	BUY	$105.79 - $124.53 $124,197 - $146,198	1,174 Added 8.98%	14,241 $1.65 Million
Q1 2021 Apr 19, 2021	SELL	$108.84 - $128.23 $185,028 - $217,990	-1,700 Reduced 11.51%	13,067 $1.57 Million
Q4 2020 Feb 04, 2021	SELL	$105.0 - $114.42 $78,750 - $85,815	-750 Reduced 4.83%	14,767 $1.62 Million
Q3 2020 Oct 26, 2020	SELL	$91.64 - $111.29 $45,820 - $55,645	-500 Reduced 3.12%	15,517 $1.69 Million
Q1 2020 Apr 17, 2020	SELL	$62.82 - $91.86 $31,410 - $45,930	-500 Reduced 3.03%	16,017 $1.26 Million
Q4 2019 Jan 31, 2020	SELL	$78.51 - $87.4 $215,902 - $240,350	-2,750 Reduced 14.27%	16,517 $1.44 Million
Q3 2019 Oct 16, 2019	SELL	$81.84 - $88.74 $72,182 - $78,268	-882 Reduced 4.38%	19,267 $1.61 Million
Q2 2019 Jul 22, 2019	SELL	$72.88 - $85.0 $39,865 - $46,495	-547 Reduced 2.64%	20,149 $1.7 Million
Q1 2019 Apr 18, 2019	SELL	$66.22 - $80.06 $66,220 - $80,060	-1,000 Reduced 4.61%	20,696 $1.65 Million
Q4 2018 Jan 28, 2019	SELL	$65.56 - $74.27 $15,078 - $17,082	-230 Reduced 1.05%	21,696 $1.57 Million
Q3 2018 Oct 22, 2018	SELL	$60.81 - $73.36 $106,417 - $128,380	-1,750 Reduced 7.39%	21,926 $1.61 Million
Q2 2018 Jul 25, 2018	BUY	$57.57 - $63.54 $80,195 - $88,511	1,393 Added 6.25%	23,676 $1.44 Million
Q1 2018 Apr 23, 2018	SELL	$56.27 - $63.62 $865,939 - $979,048	-15,389 Reduced 40.85%	22,283 $1.34 Million
Q4 2017 Apr 23, 2018	BUY	$53.68 - $57.47 $2.02 Million - $2.17 Million	37,672	37,672 $2.15 Million

Others Institutions Holding ABT

# of Institutions

3,459

Shares Held

1.34B

Call Options Held

10.5M

Put Options Held

8.72M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $229B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Trecaso Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wells Trecaso Financial Group, LLC with notifications on news.

Account

Wells Trecaso Financial Group, LLC Abbott Laboratories Transaction History